Clinical Trial Update: A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients [Phase 2]

View source ↗

Summary

Phase II, double-blind study evaluating two doses of Vandetanib (ZACTIMA, ZD6474) in combination with FOLFIRI versus FOLFIRI alone in colorectal cancer. Results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Zactima (vandetanib)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-05-24